Skip to main content

We earn commissions from the providers listed here. No provider buys a position, a rating, or a listing. The order is set by hand, and we do not claim it is independent of what we earn. Advertising Disclosure

Manytreatments
Manytreatments
BrowseCategoriesCompareMedicationsBy State
TreatmentsWeight LossED TreatmentHair LossTRT
AboutFAQContact
CategoriesCompareMedicationsBy StateWeight LossED TreatmentHair LossTRTHow We Rate

manytreatments

Compare telehealth providers for weight loss, erectile dysfunction, hair loss, TRT, women's health, mental health, and premature ejaculation treatment. Find pricing, reviews, and licensed US doctors in all 50 states.

Trustpilot
Google Safe Browsing verified site

Treatments

  • Weight Loss
  • ED Treatment
  • TRT
  • Hair Loss
  • Women's Health
  • PE Treatment
  • Mental Health
  • View All Treatments →

Top Brands

  • Hims
  • Medvi
  • Ro
  • Shed
  • Eden
  • Sesame Care
  • Maximus
  • Peter MD
  • View All Brands →

Resources

  • Compare Brands
  • Browse by State
  • Medications
  • Tools
  • Guides
  • Cost Guides
  • Statistics & Price Indexes
  • FAQ
  • About Us
  • Contact Us
  • How We Rate
  • Sitemap

Legal

  • Privacy Policy
  • Terms of Service
  • Affiliate Disclosure
  • Medical Disclaimer
  • Editorial Policy
  • Cookie Policy
  • California Privacy Notice (CCPA)
  • Accessibility Statement

Follow Us

  • Medium
  • YouTube
  • LinkedIn
  • Twitter/X
  • Instagram
  • Threads
© 2026 ManyTreatments.com. All rights reserved.Advertising DisclosureWe may earn commissions from affiliate links.

Content is for informational purposes only and is not medical advice. Compounded medications are not FDA-approved for safety, effectiveness, or quality. Medical Disclaimer

  1. Home
  2. Compare
  3. Medvi vs HealthRx
Eric GoldWritten by Eric GoldEditor-in-Chief
Updated onOctober 07, 2026
Medvi telehealth platform
Medvi
VS
HealthRx telehealth platform
HealthRx
Visit MedviVisit HealthRx

Medvi vs HealthRx

Complete 2026 Comparison for Weight Loss

Weight Loss

Our Verdict

Both run erectile dysfunction and weight loss. HealthRx is lower in both: $99 a month in weight loss verified as of 2026-08-21 against MEDVi's $299 a month ongoing verified as of 2026-09-12, and $69 a month in ED, undated in our file, against MEDVi's $114 verified as of 2026-09-06. MEDVi's $179 is a first month, not the plan. The FDA issued MEDVi, LLC a warning letter in February 2026, MARCS-CMS 721455.

Pick Medvi

You want one compounded combination dose for ED, or a weight-loss plan with dietician visits and coaching included and no separate membership charge in our record.

Pick HealthRx

You want the lower starting price in either category, one bundled figure covering the visit, the medication and shipping on the erectile-dysfunction line, and the option to switch between an as-needed and a daily tablet.

HealthRx holds the lower floor in both categories, by $200 a month on the ongoing weight-loss figure. MEDVi's $179 is a first month and $299 is the ongoing price. MEDVi carries an FDA warning letter from February 2026; HealthRx carries a company we could not identify.

Quick Answer

Best overallMedvi

Medvi is our overall pick for weight loss, based on our rating and feature coverage.

Top Weight Loss Providers

Our Top Choice
1
TrimRx logo

GLP-1 Weight Loss From $179/mo - Free 2-Minute Assessment

  • Compounded GLP-1 (semaglutide) from $179/mo, GLP-1 + GIP (tirzepatide) from $259/mo
  • Brand-name Ozempic®, Mounjaro®, Zepbound® and Wegovy® also available
  • Free 2-minute qualification quiz and FREE doctor consultation - no cost, no obligation
  • Free tracked shipping straight to your door after approval
TrimRx displays LegitScript certificate 31417191, checked September 19, 2026Cert. 31417191September 19, 2026
9.4
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
Most Popular
2
Medvi logo

No Separate Membership Fee Listed on the Compounded Semaglutide Plan (Checked Sep 2026)

  • Doctor-guided compounded GLP-1 care, 100% online. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • Free dietician visits and care coaching included with your plan
  • Doctor-formulated plans adjusted as your body responds
  • Fast, discreet shipping to your door
LegitScript lists Medvi as certified, checked on LegitScript's status page September 20, 2026CertifiedSeptember 20, 2026
9.2
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
3
Fridays logo

Compounded Semaglutide From $150/mo on Prepaid Plans

  • Compounded semaglutide from $150/mo, tirzepatide from $240/mo on prepaid plans
  • Insurance concierge works to maximize your coverage
  • GLP-1 microdosing option and a custom plan in under 3 minutes
Fridays displays LegitScript certificate 18528873, checked September 19, 2026Cert. 18528873September 19, 2026
9.2
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review

Provider Overview

Medvi logo
9.2

Our editorial rating 9.2/10Trustpilot: 4.3/5 from 15,167 reviews, checked Nov 1, 2026

Medvi prescribes compounded GLP-1 weight loss medications through licensed US providers, bundling dietician visits and care coaching into a flat monthly price. Compounded drugs are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.

Rating9.2/10
Free ConsultationYes
Free ShippingYes
HSA/FSAYes
Founded2023
HQUnited States
Visit MedviRead Full Review
HealthRx logo
9.1

HealthRx is a physician-supervised GLP-1 weight loss telehealth platform offering compounded semaglutide and tirzepatide from $99/mo, with a 30-day money-back guarantee, no insurance required, and free shipping in 24-48 hours.

Rating9.1/10
Free ConsultationYes
Free ShippingYes
HSA/FSAYes
Founded2023
HQUnited States
Visit HealthRxRead Full Review
VS

Feature Comparison

Feature comparison between Medvi and HealthRx
FeatureMedviMedviHealthRxHealthRx
Rating9.2/109.1/10
Founded20232023
Free ConsultationYesYes
Free ShippingYesYes
Accepts InsuranceNoNo
HSA/FSA AcceptedYesYes
Mobile AppNoNo
Consultation TypeVideo, AsynchronousAsynchronous
Shipping Time3-5 business days24-48 hours

Pricing Comparison

Pricing comparison between Medvi and HealthRx across treatment categories
TreatmentMedviHealthRx
Weight Loss$299/month$99/month

Prices shown are starting costs. Actual pricing varies by treatment plan and medication.

Pros and Cons

Medvi

Pros

  • Introductory pricing at $179 first month
  • Free dietician visits included
  • Ongoing care coaching between refills
  • All-inclusive cash pricing
  • Simple 3-step onboarding flow

Cons

  • Price increases to $299/month after first month
  • Does not accept insurance
  • Newer company with limited reviews
  • Weight loss only focus
HealthRx

Pros

  • Compounded semaglutide from $99/mo on the 12-month plan
  • 30-day money-back guarantee, full refund if not approved
  • Same price at every dose
  • Free overnight shipping in 24-48 hours
  • HSA/FSA eligible

Cons

  • $99/mo requires the 12-month plan; 3-month is $133/mo
  • Compounded medications are not FDA-approved
  • Online-only, cash-pay with no insurance billing
  • Weight loss only focus

Which Should You Choose?

MedviChoose Medvi if you:
  • Patients seeking complete GLP-1 program
  • Those wanting metabolic insights
  • Patients preferring personalized coaching
  • First-time GLP-1 users wanting guidance
Visit Medvi
HealthRxChoose HealthRx if you:
  • Those wanting the lowest cash GLP-1 price
  • People without GLP-1 insurance coverage
  • Anyone who wants free shipping within 24-48 hours
  • Those wanting a money-back guarantee
Visit HealthRx

Who This Is For

This is for
  • You want to compare medication options, monthly costs, and state availability across multiple telehealth providers.
  • You prefer reviewing licensed provider programs independently before committing to a subscription.
  • The FDA-approved labeling for Wegovy and Zepbound covers weight reduction in adults with a BMI of 30 or higher, and in adults with a BMI of 27 or higher who have at least one weight-related condition such as type 2 diabetes or high blood pressure. If you are near either number, ask a licensed provider where you fall before choosing a platform.
  • If you are pregnant or planning a pregnancy, the Wegovy label directs you to stop semaglutide once pregnancy is recognized and two months before a planned pregnancy, so raise it at intake.
  • If you are breastfeeding, ask the provider what the label for the specific medication says, because the labels differ.
  • If you have a history of disordered eating, tell the provider at intake, because it is part of what a prescriber weighs before starting a weight loss medication.
  • If you have had bariatric surgery or are considering it, tell the provider at intake, because it changes what a prescriber will consider.
  • A remote visit cannot include a physical exam or in-office testing. If that matters for your situation, raise it with a licensed provider before choosing a platform.
  • If this is an emergency, call 911 or go to the nearest emergency room. Telehealth is not for emergency care.

These notes are not a medical screening: a licensed provider decides after an intake review whether a treatment is appropriate for you.

About This Comparison

Our Editorial Standards

This medvi vs healthrx provider comparison is independently researched by our editorial team. We compare telehealth services based on publicly available information including pricing, available treatments, and service areas. Our ratings are editorial judgments, not tallies of reviews.

Independent Research: We do not accept payment for rankings or favorable reviews
Affiliate Disclosure: We may earn commissions from qualifying purchases at no extra cost to you
Regular Updates: Content is reviewed and updated monthly for accuracy
Licensed Providers Only: All listed services employ US-licensed healthcare providers

Not Medical Advice: This comparison is for informational purposes only. We are not healthcare providers. Always consult with a licensed physician before starting any treatment. Read our full medical disclaimer and editorial policy.

Independent ResearchNo paid placements
Fact-Checked InformationVerified against official sources
Regularly UpdatedLast updated October 7, 2026
Licensed Providers OnlyAll listed services are US-licensed

MEDVi vs HealthRx: Where the First-Month Price Stops Being the Price

Eric GoldWritten by Eric GoldEditor-in-Chief
10 min readUpdated October 7, 2026

Table of Contents

These two cover exactly the same ground, erectile dysfunction and weight loss, and HealthRx holds the lower starting price in both. The number most likely to trip you up is on the MEDVi side: its weight-loss plan reads $179 for the first month and $299 a month after that, so the figure in the advertising is an introductory month rather than the plan. There is also a regulatory fact to put on the table early, because the FDA issued MEDVi, LLC a warning letter in February 2026.

They cover the same two things, so take them one at a time

MEDVi and HealthRx each list two live categories in our data, erectile dysfunction and weight loss, and nothing else. That makes this a cleaner comparison than most, as long as you read the half you actually came for.
In weight loss the distance is large. HealthRx lists $99 a month, verified as of 2026-08-21. MEDVi lists $299 a month ongoing, verified as of 2026-09-12. That is $200 a month between the two ongoing figures.
In erectile dysfunction, MEDVi lists $114 a month, verified as of 2026-09-06. The HealthRx ED floor is $69 a month, a figure we hold with no verification date on file, so we will name it and we will not date it. Treat that side of the ED comparison as indicative rather than current, and check the live checkout before you decide on it.
  • MEDVi erectile dysfunction floor: $114/mo, verified as of 2026-09-06
  • MEDVi weight loss floor: $299/mo ongoing, with a $179 first month, verified as of 2026-09-12
  • HealthRx weight loss floor: $99/mo, verified as of 2026-08-21
  • HealthRx erectile dysfunction floor: $69/mo, with no verification date on file

The MEDVi weight-loss number that gets quoted wrong

Our price record for MEDVi reads $299 a month ongoing with a $179 first month, verified as of 2026-09-12. The $179 is an introductory month. If you budget on it you will be $120 short from month two onward.
Because that shape invites a mistake, here is the arithmetic in full. A first year at list is $179 plus eleven months at $299, which comes to $3,468. HealthRx on its twelve-month plan at $99 a month comes to $1,188 over the same span. Both totals assume list figures hold for a year, which is not something either company undertakes to do.
One thing our record is clear about is that it holds no separate membership charge on top of the $299. That matters in this category, where the headline medication price is often only half of the bill. MEDVi's record with us also lists free dietician visits and care coaching as included in the plan, and plans its doctors adjust as your body responds.

Four drugs in one dose, or a tablet you can switch

MEDVi's ED product is the MEDVi Quad, which its listing describes as a single dose combining tadalafil, sildenafil, vardenafil and L-citrulline. It is compounded, and compounded drug products are not FDA-approved as finished drug products, so the FDA has not reviewed that formula for safety, effectiveness or quality. MEDVi's listing notes that tadalafil is active for up to 36 hours according to its FDA label, which covers as-needed Cialis on its own rather than a compounded four-drug combination.
HealthRx runs the opposite shape: as-needed sildenafil and tadalafil, plus a daily low-strength tadalafil option, inside the $69 floor. Our listing says you can try an as-needed tablet and a daily option and move between them without a new visit. Alongside those it lists a PT-141 injection and a prescription arousal cream, which it describes as aimed at desire rather than blood flow. Both of those are compounded and have not been reviewed by the FDA.
So the ED choice here is between one combined compounded dose and a menu of single-ingredient tablets with compounded options at the edges. Which of those suits you is a conversation for the prescriber who signs off on your intake, and neither company publishes enough in our file for us to take that further.

What the FDA wrote to MEDVi, LLC

On February 20, 2026 the FDA issued MEDVi, LLC a warning letter citing misbranding under sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act, MARCS-CMS 721455. Reviewing medvi.io in December 2025, the agency said labels bearing the MEDVi name implied that MEDVi compounds the drugs when it does not, and that two claims equating its compounded product with named brand-name medicines implied an FDA approval that compounded drugs do not have. We verified this note on August 22, 2026.
We searched FDA's warning letter index for MEDVi, LLC on 2026-10-07: the entry for MARCS-CMS 721455 listed no response letter and no close-out letter.
MEDVi states that medvi.io is affiliate-operated rather than company-operated. We could not verify that, and the letter is addressed to MEDVi, LLC.
We hold no regulatory notice for HealthRx, and this is where the gap in our records on that brand matters. Because we could not identify the legal entity behind it when we checked on 2026-08-23, our search of FDA enforcement records could only run against the brand name and the domain. An empty result under those conditions is not a clearance, and we are not going to present it as one.

Neither one charges you for a no, and they get there differently

MEDVi's wording is that if you do not qualify, you do not pay, after a three-minute private evaluation with approval inside 24 hours, with free rush shipping in plain packaging after that. HealthRx offers a full refund if a licensed provider does not approve you on its weight-loss line, a full refund on the medication if you are not approved on its erectile-dysfunction line, and free overnight shipping in plain packaging to all 50 states on that erectile-dysfunction line.
Read those two carefully, because they are not the same promise. One avoids the charge and the other returns it, and a refund assumes a payment happened first. If that distinction matters to your account balance, ask which one applies to you before a card goes in.
HealthRx displays LegitScript certification seal 50087439, which we checked with LegitScript on 2026-09-19. We hold no certification record for MEDVi, which again is a gap in our file rather than a statement about the company.
On fit, only one side gives us anything to quote. Our fit notes for MEDVi name adults with a BMI over 27 who want doctor-prescribed compounded semaglutide at home, and a flat cash price without insurance. HealthRx publishes no equivalent note for its weight-loss plan in our data, so we cannot tell you who it says that plan is built for.

How We Compared Medvi vs HealthRx

How we put this page together

Each price is the floor on that brand's live row for that category in our database, the lowest configuration we were able to verify, printed with the date the row was last verified. One figure on this page, the HealthRx erectile-dysfunction floor, has no verification date in our file, and we flag it as undated every time it appears rather than borrowing a date from a different row.

Formula and service details are each brand's own published description, including compounded status, which we restate wherever a compounded preparation is named.

The regulatory section is taken from the FDA warning letter itself and from our check of the agency's warning letter index against the MARCS-CMS number on the date stated. Where a brand disputes part of the record, as MEDVi does on who operates medvi.io, we print the dispute and say whether we could verify it.

Final Verdict: Medvi vs HealthRx

Reading this as a buyer

Price first, because the spread is not subtle. HealthRx is $200 a month lower on the ongoing weight-loss floor and lower on the ED floor as well, though the ED figure on its side carries no verification date in our records. MEDVi's $179 is a first month and $299 is the plan, and anyone quoting MEDVi at $179 a month is quoting you the wrong number.

Then the product shape. MEDVi's ED answer is one compounded combination dose, with dietician visits and care coaching included on the weight-loss side. HealthRx's answer is a switchable tablet menu with compounded options at the edges, a single bundled price on its erectile-dysfunction line that covers the visit, the medication and shipping, and a LegitScript seal we checked with LegitScript on 2026-09-19.

Then the record. MEDVi has an FDA warning letter from February 2026 whose entry in the agency's index we searched on 2026-10-07, and HealthRx has a company we could not identify at all. Those are different kinds of unknown, and neither one is nothing. Decide which you would rather carry.

Visit MedviVisit HealthRx

Frequently Asked Questions

Is MEDVi or HealthRx cheaper for weight loss?

HealthRx, by $200 a month at the ongoing floors. HealthRx lists $99 a month, verified as of 2026-08-21. MEDVi lists $299 a month ongoing, verified as of 2026-09-12. Both are floors for the lowest configuration we could verify rather than a quote.

Is the MEDVi weight loss price $179 or $299?

Both, in order. MEDVi's own label reads $179 for the first month and $299 a month ongoing, verified as of 2026-09-12. The $179 is introductory, so plan on $299 from the second month. Our record also holds no separate membership charge on top of it.

Which one is cheaper for ED treatment?

HealthRx lists $69 a month and MEDVi lists $114 a month. The MEDVi figure was verified as of 2026-09-06. The HealthRx figure is one we hold with no verification date on file, so check it live before you rely on the comparison.

Is the MEDVi Quad ED formula FDA approved?

No. MEDVi's own listing describes it as compounded, and compounded drug products are not FDA-approved as finished drug products, which means the FDA has not reviewed that combination for safety, effectiveness or quality. The listing does cite tadalafil's FDA label for the 36-hour window.

What did the FDA's warning letter to MEDVi say?

On February 20, 2026 the FDA issued MEDVi, LLC a warning letter citing misbranding under sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act, MARCS-CMS 721455. Reviewing medvi.io in December 2025, the agency said labels bearing the MEDVi name implied that MEDVi compounds the drugs when it does not, and that two claims equating its compounded product with named brand-name medicines implied an FDA approval compounded drugs do not have. We searched FDA's warning letter index for MEDVi, LLC on 2026-10-07: the entry for MARCS-CMS 721455 listed no response letter and no close-out letter. MEDVi says medvi.io is affiliate-operated rather than company-operated; we could not verify that, and the letter is addressed to MEDVi, LLC.

Will either one charge me if I am not approved for treatment?

Each says no, by a different route. MEDVi's wording is that if you do not qualify you do not pay. HealthRx offers a full refund of the charge if a licensed provider does not approve you, which assumes you paid first. Confirm which applies before you enter a card.

Does either of them offer anything besides tablets for ED?

HealthRx does: its listing names a PT-141 injection and a prescription arousal cream, both compounded and both not reviewed by the FDA, which it describes as aimed at desire rather than blood flow. MEDVi's single ED product is the compounded MEDVi Quad dose.

Sources & References

Our comparisons are informed by official sources and regulatory guidelines. We encourage you to verify information with authoritative sources.

    Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards

    Related Comparisons

    HimsVSMedviHimsVSHealthRxHersVSMedviHersVSHealthRxRoVSMedviRoVSHealthRx

    Start With a Top Weight Loss Provider

    Our Top Choice
    1
    TrimRx logo

    GLP-1 Weight Loss From $179/mo - Free 2-Minute Assessment

    • Compounded GLP-1 (semaglutide) from $179/mo, GLP-1 + GIP (tirzepatide) from $259/mo
    • Brand-name Ozempic®, Mounjaro®, Zepbound® and Wegovy® also available
    • Free 2-minute qualification quiz and FREE doctor consultation - no cost, no obligation
    • Free tracked shipping straight to your door after approval
    TrimRx displays LegitScript certificate 31417191, checked September 19, 2026Cert. 31417191September 19, 2026
    9.4
    OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
    ★★★★★
    See PricingRead full review
    Most Popular
    2
    Medvi logo

    No Separate Membership Fee Listed on the Compounded Semaglutide Plan (Checked Sep 2026)

    • Doctor-guided compounded GLP-1 care, 100% online. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
    • Free dietician visits and care coaching included with your plan
    • Doctor-formulated plans adjusted as your body responds
    • Fast, discreet shipping to your door
    LegitScript lists Medvi as certified, checked on LegitScript's status page September 20, 2026CertifiedSeptember 20, 2026
    9.2
    OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
    ★★★★★
    See PricingRead full review
    3
    Fridays logo

    Compounded Semaglutide From $150/mo on Prepaid Plans

    • Compounded semaglutide from $150/mo, tirzepatide from $240/mo on prepaid plans
    • Insurance concierge works to maximize your coverage
    • GLP-1 microdosing option and a custom plan in under 3 minutes
    Fridays displays LegitScript certificate 18528873, checked September 19, 2026Cert. 18528873September 19, 2026
    9.2
    OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
    ★★★★★
    See PricingRead full review

    Related Resources

    Brand Review

    Medvi Review

    Brand Review

    HealthRx Review

    Brand Review

    Is Medvi Legit?

    Brand Review

    Is HealthRx Legit?

    Guide

    Medvi Alternatives

    Guide

    HealthRx Alternatives

    Eric Gold
    Eric GoldEditor-in-Chief

    Eric Gold is a writer and editor with a background in digital media and consumer research. He has spent the last several years covering the health and wellness industry, with a particular focus on telehealth services and direct-to-consumer healthcare. Eric believes that access to clear, unbiased information should not require a medical degree. When he is not reviewing telehealth platforms, he enjoys hiking, cooking, and following the stock market a little too closely.

    Medical Disclaimer: The information on this page is for educational purposes only and is not medical advice. Always consult with a licensed healthcare provider before starting any treatment. Read our full medical disclaimer.

    How we scoreOur 1 to 10 brand scores are our own editorial judgment. They are not aggregated from third-party review platforms and they are not the output of a scoring formula.

    What a starting price isA starting price is the lowest figure a company lists for a category, not a quote. What you pay follows a clinician's review of your intake, and where a required membership or care plan sits alongside the medication we publish the two charges combined.

    Reading a warning letterA close-out letter is FDA's record that it has evaluated a company's corrective actions, so the absence of one means the file is not closed on the public record, and nothing more than that.

    Regulatory noticeRegulatory note (verified October 8, 2026): On February 20, 2026 the FDA issued MEDVi, LLC a warning letter (MARCS-CMS 721455) citing misbranding under sections 502(a) and 502(bb) of the FD&C Act. Reviewing medvi.io in December 2025, the FDA said labels bearing "MEDVi" implied MEDVi compounds the drugs when it does not, and that site copy presenting the compounded drug as having the same active ingredient as Wegovy and Ozempic, and as Mounjaro and Zepbound, implied an FDA approval compounded drugs do not have. The letter adds that introducing or delivering the products it identifies into interstate commerce is a prohibited act under section 301(a), that receiving them in interstate commerce and delivering or offering to deliver them also violates section 301(c), and that a compounded drug product must meet the conditions of section 503A or 503B of the FD&C Act to be exempt from certain requirements, including the new drug approval requirements. When we checked FDA's warning letter index for MEDVi, LLC on October 8, 2026 it showed no response letter and no close-out letter entered against it, so the letter is not closed out on the public record. MEDVi states medvi.io is affiliate-operated rather than company-operated; we could not verify that, and the letter is addressed to MEDVi, LLC. Read the FDA letter

    Verification limitationVerification note (checked August 23, 2026): we could not identify the legal entity behind HealthRx through public records. Its website does not name an operating company, its domain registration is privacy-shielded, and we could not confirm a listing in any business registry or accreditation database we checked. This is not a finding of wrongdoing. It means our usual checks, including our search of FDA enforcement records, could only be run against the brand name and domain rather than a confirmed company.